Inventor
SILL KEVIN N
US34 patents
⚠️ This page may combine multiple inventors who share the name “SILL KEVIN N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTEZYNE TECHNOLOGIES INC
7 patentsUS7638558B2Dec 29, 2009
Polymeric micelles for drug delivery
INTEZYNE TECHNOLOGIES INC80 citations98
US7560588B2Jul 14, 2009
Poly(ethylene glycol) containing chemically disparate endgroups
INTEZYNE TECHNOLOGIES INC39 citations96
US7799339B2Sep 21, 2010
Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
INTEZYNE TECHNOLOGIES INC15 citations92
US7618944B2Nov 17, 2009
Encapsulated amyloid-beta peptides
INTEZYNE TECHNOLOGIES INC34 citations92
US8779008B2Jul 15, 2014
Polymeric micelles for drug delivery
INTEZYNE TECHNOLOGIES INC9 citations83
US7893277B2Feb 22, 2011
Poly(ethylene glycol) containing chemically disparate endgroups
INTEZYNE TECHNOLOGIES INC2 citations62
US8629186B2Jan 14, 2014
Polymer micelles containing anthracyclines for the treatment of cancer
INTEZYNE TECHNOLOGIES INC3 citations57
SILL KEVIN N
7 patentsUS8263665B2Sep 11, 2012
Polymeric micelles for drug delivery
SILL KEVIN N66 citations97
US8299128B2Oct 30, 2012
Compositions comprising polymeric micelles for drug delivery
SILL KEVIN N12 citations92
US8263663B2Sep 11, 2012
Azide functionalized peptide targeting groups
SILL KEVIN N10 citations92
US8980326B2Mar 17, 2015
Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
SILL KEVIN N14 citations83
US8207353B2Jun 26, 2012
Poly(ethylene glycol) containing chemically disparate endgroups
SILL KEVIN N3 citations62
US8524784B2Sep 3, 2013
Polymer micelles containing anthracylines for the treatment of cancer
SILL KEVIN N1 citations50
US8524783B2Sep 3, 2013
Polymer micelles containing anthracylines for the treatment of cancer
SILL KEVIN N0 citations50
TYNDALL FORMULATION SERVICES LLC
5 patentsUS10836869B1Nov 17, 2020
Polymer excipients for drug delivery applications
TYNDALL FORMULATION SERVICES LLC13 citations83
US11286344B2Mar 29, 2022
Polymer excipients for drug delivery applications
TYNDALL FORMULATION SERVICES LLC2 citations70
US10918619B1Feb 16, 2021
Formulations of paclitaxel with poly(amino acid) block polymers
TYNDALL FORMULATION SERVICES LLC4 citations70
US11891482B2Feb 6, 2024
Polymer excipients for drug delivery applications
TYNDALL FORMULATION SERVICES LLC0 citations60
US11857630B2Jan 2, 2024
Formulations of SN-38 with poly(amino acid) block polymers
TYNDALL FORMULATION SERVICES LLC0 citations60
BREITENKAMP KURT
3 patentsUS8268936B2Sep 18, 2012
Synthesis of hybrid block copolymers and uses thereof
BREITENKAMP KURT8 citations83
US8066824B2Nov 29, 2011
Covalent modification of metal surfaces
BREITENKAMP KURT9 citations82
US8212083B2Jul 3, 2012
Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
BREITENKAMP KURT0 citations41
H LEE MOFFITT CANCER CT & RES
3 patentsUS12173087B2Dec 24, 2024
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations60
US11230568B2Jan 25, 2022
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations60
US10329326B2Jun 25, 2019
Melanocortin 1 receptor ligands and methods of use
H LEE MOFFITT CANCER CT & RES0 citations50